Identify
Identify eligible patients, switch risk, and early lapse signals across Komodo’s numerous linked journeys. Claims, EHR, and laboratory data surface risk signals, with each exit point instrumented and owned.
Powered by Claims Data + Cortex
31%
of specialty prescriptions analyzed went unfilled
~50%
average adherence to long-term therapy among patients with chronic diseases
12 days
to specialty treatment initiation through integrated pharmacy care, vs. 18 days externally
Patients drop off at different points: prior authorization, affordability, treatment initiation, or refill. Because each point may sit with a different team, no one owns the full journey. Hub enrollment may look strong while refill patterns show continued drop-off.
Conventional programs engage on a schedule, but patients discontinue therapy at specific moments. If programs cannot recognize and respond to those moments, support comes too late.
Claim status, refill timing, and engagement signals can identify patients at risk of abandonment earlier. Programs can act before drop-off occurs.
E-prior authorization, benefits verification, and enrollment are becoming more automated. Time to first dose becomes a key performance measure.
Omnichannel engagement can adapt to each patient's needs, preferred channel, and barriers. AI manages routine interactions. Human support focuses on more complex needs.
Sponsors and partners are moving toward adherence- and outcome-linked terms. Value is measured by patients staying on therapy, not by activity alone.
The shift is clear: manage the patient journey as one connected, accountable, and continuously learning system.
Identify eligible patients, switch risk, and early lapse signals across Komodo’s numerous linked journeys. Claims, EHR, and laboratory data surface risk signals, with each exit point instrumented and owned.
See how advanced analytics helped a global pharma company reduce time to patient insights for 80% faster decision-making.
Learn how integrated data and advanced analytics can help life sciences teams generate faster, actionable patient insights across brand lifecycle.
Learn how life sciences teams can connect online and offline interactions to understand what drives HCP and patient behavior and improve attribution.
Eligible patients, switch risk, and lapse signals from numerous linked patient journeys.
Enrollment, benefits verification, and ePA run to a days-long SLA.
Abandonment risk models triggering intervention before the exit.
Personalized support across app, text, call, and portal, compliant by design.
Refill orchestration, barrier navigation, and lapse re-engagement.
Full program run with outcome reporting that sponsors can stand behind.
Abandonment concentrates at friction points: prior authorization delays, cost surprise, and unsupported first weeks on therapy.
Indegene automates the access friction and intervenes on predictive signals from Komodo's linked claims, EHR, and laboratory data to intervene before patients drop off..
Adherence improves when support matches each patient's actual barriers and arrives at the moment of risk.
Indegene runs predictive, omnichannel programs across the full therapy arc.
Time to therapy measures the days from prescription to first dose, and every added day raises abandonment risk.
Indegene's automated onboarding compresses it from weeks to days.
Hub vendors are paid for enrollment activity.
Indegene owns the whole journey with instrumentation at every exit, and ties fees to patients actually on therapy.
Analyze funnel data from prescription through month 12 to identify exit points, design a zero drop-off journey, and define clear retention milestones.